The healthcare team covers Q1 results from pharma and medtech companies and provides a wrap-up of the key takeaways.
Eli Lilly, Novartis, GE HealthCare, and Stryker, amongst others, are covered in this episode. Credit: Dadann/Shutterstock.com.
With pharma and medtech Q1 earnings season now at a close, some sector areas performed better than others.
In this episode, Robert Barrie, editor for Pharmaceutical Technology, and Ross Law, reporter at Medical Device Network, discuss the key trends from the quarter. In pharma, weight loss therapies and patent expirations dominated bottom lines. Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
